OMX Nordic 40
2.516,36
PKT
+48,14
PKT
+1,95
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.02.16 | AstraZeneca buy | UBS AG | |
| 09.02.16 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
| 08.02.16 | Volvo (B) buy | Citigroup Corp. | |
| 08.02.16 | AstraZeneca Halten | Independent Research GmbH | |
| 08.02.16 | Volvo (B) Underweight | JP Morgan Chase & Co. | |
| 08.02.16 | Novo Nordisk Sell | UBS AG | |
| 08.02.16 | AstraZeneca Hold | HSBC | |
| 05.02.16 | AstraZeneca buy | Deutsche Bank AG | |
| 05.02.16 | Volvo (B) Hold | S&P Capital IQ | |
| 05.02.16 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 05.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 05.02.16 | AstraZeneca buy | UBS AG | |
| 05.02.16 | Ericsson (Telefon L.M.Ericsson) (B) buy | UBS AG | |
| 05.02.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 05.02.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 04.02.16 | AstraZeneca Hold | S&P Capital IQ | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk Neutral | UBS AG | |
| 04.02.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.02.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 04.02.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 03.02.16 | Novo Nordisk verkaufen | S&P Capital IQ | |
| 02.02.16 | Nokia buy | S&P Capital IQ | |
| 01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.16 | Nokia Neutral | Merrill Lynch & Co., Inc. | |
| 01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
| 01.02.16 | Novo Nordisk Neutral | UBS AG | |
| 01.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.02.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.01.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 28.01.16 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
| 28.01.16 | Ericsson (Telefon L.M.Ericsson) (B) kaufen | Independent Research GmbH | |
| 28.01.16 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 28.01.16 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 28.01.16 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
| 28.01.16 | Ericsson (Telefon L.M.Ericsson) (B) buy | UBS AG | |
| 26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. |